Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8045462 | 1.00 | DRD2 (0.54) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL8045452 | 1.00 | DRD2 (0.54) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL5351739 | 0.95 | DRD2 (0.58) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL5351735 | 0.95 | DRD2 (0.58) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL6456816 | 0.91 | DRD2 (0.46) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL6456822 | 0.91 | DRD2 (0.46) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL10765110 | 0.91 | DRD2 (0.51) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL10765104 | 0.91 | DRD2 (0.51) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL9258683 | 0.91 | DRD2 (0.54) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL9258676 | 0.91 | DRD2 (0.54) | DRD2CYP2C9MAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57165328-A | — | — | None | — | — | JP | disclosed |
| US-20230287272-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE | DIC CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-20230183573-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230183573-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230183572-A1 | LIQUID CRYSTAL COMPOSITION WITH GOOD FREQUENCY DEPENDENCE AND LIQUID CRYSTAL DISPLAY ELEMENT | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230183572-A1 | LIQUID CRYSTAL COMPOSITION WITH GOOD FREQUENCY DEPENDENCE AND LIQUID CRYSTAL DISPLAY ELEMENT | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| WO-2021253624-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT OR LIQUID CRYSTAL DISPLAY | 石家庄诚志永华显示材料有限公司 | 2021-12-23 | — | — | WO | disclosed |
| WO-2021253628-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT, AND LIQUID CRYSTAL DISPLAY | 石家庄诚志永华显示材料有限公司 | 2021-12-23 | — | — | WO | disclosed |
| WO-2021253626-A1 | LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT AND LIQUID CRYSTAL DISPLAY DEVICE | 石家庄诚志永华显示材料有限公司 | 2021-12-23 | — | — | WO | disclosed |
| EP-0090671-B1 | CARBOCYLIC ESTERS HAVING LIQUID-CRYSTAL PROPERTIES AT HIGH TEMPERATURES | Chisso Corporation (JP) | 1985-06-19 | — | — | EP | disclosed |
| US-4502974-A | SUBSTITUTED WITH HALOGEN OR NITRILE | CHISSO CORPORATION (JP) | 1985-03-05 | — | — | US | disclosed |
| US-4472293-A | High temperature liquid crystal substances of four rings and liquid crystal compositions containing the same | CHISSO CORPORATION (JP) | 1984-09-18 | — | — | US | disclosed |
| EP-0062470-B1 | LIQUID CRYSTAL BENZENE DERIVATIVES | Chisso Corporation (JP) | 1984-08-15 | — | — | EP | disclosed |
| EP-0099099-A2 | High temperature liquid crystal substances having four rings and liquid crystal compositions containing the same | Chisso Corporation (JP) | 1984-01-25 | — | — | EP | disclosed |
| US-4422951-A | Liquid crystal benzene derivatives | CHISSO CORPORATION (JP) | 1983-12-27 | — | — | US | disclosed |
| EP-0094487-A1 | Hydroterphenyls, their preparation and their use in dielectric liquid crystal material | MERCK PATENT GmbH (DE) | 1983-11-23 | — | — | EP | disclosed |
| EP-0090671-A1 | Carbocylic esters having liquid-crystal properties at high temperatures | Chisso Corporation (JP) | 1983-10-05 | — | — | EP | disclosed |
| EP-0062470-A1 | Liquid crystal benzene derivatives | Chisso Corporation (JP) | 1982-10-13 | — | — | EP | disclosed |
| JP-S57165328-A | 4-SUBSTITUTED-(TRANS-4'-(TRANS-4\"-ALKYLCYLOHEXYL) CYCLOHEXYL)BENZENE | CHISSO CORP | 1982-10-12 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | OCIAD2, PKN2, SKP1 | DRD2 271/4885CYP2C9 3955/4885MAPT 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.